UA6102A1 - Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis - Google Patents

Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis

Info

Publication number
UA6102A1
UA6102A1 UA4772063A UA4772063A UA6102A1 UA 6102 A1 UA6102 A1 UA 6102A1 UA 4772063 A UA4772063 A UA 4772063A UA 4772063 A UA4772063 A UA 4772063A UA 6102 A1 UA6102 A1 UA 6102A1
Authority
UA
Ukraine
Prior art keywords
kemantane
patients
determination
chronic obstructive
rosette
Prior art date
Application number
UA4772063A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрій Іванович Фещенко
Юрий Иванович Фещенко
Любов Соломоновна Когосова
Любовь Соломоновна Когосова
Олена Михайлівна Рекалова
Елена Михайловна Рекалова
Світлана Олександрівна Черенько
Светлана Александровна Черенько
Original Assignee
Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського
Украинский научно-исследовательский институт фтизиатрии и пульмонологии им.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського, Украинский научно-исследовательский институт фтизиатрии и пульмонологии им. filed Critical Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського
Priority to UA4772063A priority Critical patent/UA6102A1/en
Publication of UA6102A1 publication Critical patent/UA6102A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Method is realized through setting in blood sample from patient reaction of E-rosette-formation of lymphocytes with sheep erythrocytes before prescription of preparation. To increase accuracy of the method additional sample of lymphocytes is treated with kemantane in dose of 0.05 mg/ml during 30 minutes, and at increase of rosette-forming cells or preservation of level of rosette-formation compared to first sample one determines sensitivity of patient to kemantane.
UA4772063A 1989-12-22 1989-12-22 Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis UA6102A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA4772063A UA6102A1 (en) 1989-12-22 1989-12-22 Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA4772063A UA6102A1 (en) 1989-12-22 1989-12-22 Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis

Publications (1)

Publication Number Publication Date
UA6102A1 true UA6102A1 (en) 1994-12-29

Family

ID=74566657

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4772063A UA6102A1 (en) 1989-12-22 1989-12-22 Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis

Country Status (1)

Country Link
UA (1) UA6102A1 (en)

Similar Documents

Publication Publication Date Title
EP0165568A3 (en) Process and device for the specific adsorption of heparin
EP0181732A3 (en) Automated photophoresis blood portion control methods and apparatus
PH25590A (en) Active specific immune suppression
ZA858676B (en) Method and system for removing immunosppressive components from the blood of mammals
AU3844297A (en) Treatment of autoimmune diseases
COATES et al. Phase-II study of recombinant α2-interferon in advanced malignant melanoma
Bigner et al. Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis
UA6102A1 (en) Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
ES8501984A1 (en) Immune complex removal and tumor specific antibody generation by immobilized protein a perfusion and postperfusion drug infusion.
FR2657783B1 (en) PROCESS FOR THE PREPARATION OF BLOOD DERIVATIVES AND DERIVATIVES OBTAINED BY THIS PROCESS.
GR3005716T3 (en)
UA6099A1 (en) Method for determination of individual sensitivity of patients with bronchial asthma to timaline
Kierkegaard-Hansen et al. Plasma renin activity during lithium treatment of patients
Golden et al. Amoxapine treatment of psychogenic vomiting and depression.
SU1622821A1 (en) Method of determining activity of catalase in blood plasma
SU1194419A1 (en) Method of treatment of chronic nonspecific salpingo-oophorites
AU578661B2 (en) Method for diagnosis of A.I.D.S.
Liewendahl et al. Effect of anticonvulsant drugs on red cell flexibility, adenosine triphosphatase activities and cation transport
UA11489A1 (en) Method for determination of activity of thymosin
UA20008A (en) Method for determination of individual sensitivity to treatment by method of transfusions of radiated with ultraviolet auto-blood in patients suffering from psoriasis
Johnson The effects of lithium on the cerebellum.
Pedersen et al. Plasma renin substrate during lithium treatment
KALANDAROV et al. Effect of high ammonia content in pressure chamber atmosphere on human adrenocortical system function
Gately et al. Effect of anti-lymphotoxin on cell-mediated cytotoxicity: Evidence for two pathways of cytolysis